Drug Shortage Report for TOBRAMYCIN INJECTION
Report ID | 66481 |
Drug Identification Number | 02230640 |
Brand name | TOBRAMYCIN INJECTION |
Common or Proper name | Tobramycin for Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 40MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 2 mL |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-11-26 |
Actual start date | |
Estimated end date | |
Actual end date | 2019-01-08 |
Shortage status | Resolved |
Updated date | 2019-01-09 |
Company comments | Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of Tobramycin for Injection 40 mg/mL MD Vial 2 mL will be available at all distribution centers effective Tuesday, January 8, 2019 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2019-01-09 | English | Compare |
v9 | 2019-01-04 | French | Compare |
v8 | 2019-01-04 | English | Compare |
v7 | 2019-01-04 | English | Compare |
v6 | 2018-12-24 | French | Compare |
v5 | 2018-12-24 | English | Compare |
v4 | 2018-11-27 | English | Compare |
v3 | 2018-11-08 | French | Compare |
v2 | 2018-11-08 | English | Compare |
v1 | 2018-11-08 | English | Compare |
Showing 1 to 10 of 10